Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. (2015)
Attributed to:
Genetic and Acquired Complement Abnormalities in Idiopathic Membranoproliferative Glomerulonephritis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.trsl.2014.10.010
PubMed Identifier: 25468487
Publication URI: http://europepmc.org/abstract/MED/25468487
Type: Journal Article/Review
Volume: 165
Parent Publication: Translational research : the journal of laboratory and clinical medicine
Issue: 2
ISSN: 1878-1810